Details of the Drug Formulations

General Information of Drug (ID: DM79VXT)

• Drug Name: PF-04971729 Drug Info
• Synonyms: Ertugliflozin; 1210344-57-2; PF04971729; UNII-6C282481IP; PF 04971729; CHEMBL1770248; 6C282481IP; AK174928; 1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose; Steglatro; (1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[321]octane-2,3,4-triol; (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[321]octane-2,3,4-triol; Ertugliflozin [USAN:INN]; C22H25ClO7; PF-4971729; SGLT2 inhibitor (oral, type 2 diabetes), Pfizer; Sodium glucose cotransporter-2 inhibitor (oral, type 2 diabetes), Pfizer; Ertugliflozin/PF-04971729

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Approved	[1]

• Cross-matching ID:
  PubChem CID: 44814423
  CAS Number: 1210344-57-2
  TTD ID: D0Q3VE
  INTEDE ID: DR0604
  ACDINA ID: D00240

Full List of Drug Formulations Containing This Drug

Ertugliflozin 15 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F07351	Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Polyethylene glycol 3350; Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Sodium starch glycolate type a potato

Ertugliflozin 5 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F07352	Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Polyethylene glycol 3350; Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Sodium starch glycolate type a potato

References

• [1] 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.